What Is Hyperbolic Tapering, and Why Does It Work?

Hyperbolic tapering means reducing your dose by smaller and smaller amounts as the dose gets lower, rather than chopping off the same number of milligrams each time.

The reason comes down to a quirk of how these drugs act on the brain. The relationship between the dose you take and the effect on your brain receptors is not a straight line. It is a curve that rises steeply at low doses and then flattens out at high doses. Because of that curve, the last few milligrams matter far more than they look like they should. A drop from 20 mg to 10 mg can feel like almost nothing, while a drop from 2 mg to 1 mg can feel enormous, even though the second cut is ten times smaller.

Hyperbolic tapering respects that curve. It keeps each step roughly equal in terms of *brain effect*, not in terms of milligrams, which is why the doses near the end get very small and the steps get very gentle.

Most people are handed a plan that looks tidy on paper: 20 mg, then 15, then 10, then 5, then stop. Sometimes it is even faster, like 20 mg straight to 10 mg for two weeks and then off. Each cut is the same size in milligrams, so it feels fair and logical.

The problem is that an even cut in milligrams is not an even cut in effect. Going from 20 mg to 15 mg might change how much of the drug's target is occupied by only a few percent. But going from 5 mg to 0, or from 2 mg to 0, can drop the brain effect by a huge amount in a single step. So the early cuts feel deceptively easy, which builds false confidence, and then the final cuts hit hard. That late wall of withdrawal is what makes so many people conclude they have relapsed or that they simply cannot stop. Usually they just hit the steep part of the curve with a step that was far too big for that point in the taper.

This is the part that gives the method its name, and it is worth understanding because it is genuinely reassuring once it clicks.

Most antidepressants and benzodiazepines work by binding to a target in the brain. For SSRIs that target is the serotonin transporter, often shortened to SERT. When researchers measured how much of that transporter a given dose actually blocks, they found the relationship is hyperbolic, following a pattern pharmacologists call the Michaelis-Menten curve. In plain terms: at low doses the receptors are mostly empty, so each milligram has a large effect; at higher doses the receptors are nearly full, so each extra milligram does very little.

A concrete example from the work of psychiatrist Mark Horowitz and pharmacologist David Taylor, published in *Lancet Psychiatry* in 2019, makes this vivid. With citalopram, a standard 20 mg dose occupies roughly 80 percent of the serotonin transporter. But about 2 mg of citalopram still produces around half of that maximum effect. So 2 mg, a dose many people dismiss as "basically nothing," is doing a great deal of work in your brain. That is precisely why stopping from a small dose can be so destabilizing, and why the answer is to make the final steps tiny rather than to muscle through them.

To keep each step gentle in terms of brain effect, the dose reductions get proportionally smaller as you go down. Instead of subtracting a fixed number of milligrams, you reduce by a percentage of your *current* dose, and you aim for a roughly even, small change in receptor occupancy at each step, often in the range of about 5 to 10 percent of occupancy per step.

In practice that produces a schedule where the milligram steps shrink dramatically toward the end. A taper might move comfortably through the higher doses, then slow right down so the last stretch includes doses like 1 mg, 0.5 mg, and lower, held for as long as your body needs at each point. The Maudsley Deprescribing Guidelines, written by Horowitz and Taylor, publish dose-by-dose tables built on exactly this logic for most common antidepressants, benzodiazepines, gabapentinoids, and z-drugs. The pace is individual: some people move every couple of weeks, others stay on a step for a month or more, and pausing when symptoms flare is part of the method, not a failure of it.

This is not just theory. In a real-world study of antidepressant tapering using gradual, hyperbolic "tapering strips" in the Netherlands, led by Jim van Os and Peter Groot, withdrawal symptoms stayed low across the process, generally rated between "very little" and "a little." Related work using these strips has reported that around 70 percent of people who had struggled to stop were able to discontinue successfully with a slow hyperbolic approach.

The detail that matters most if you have failed before: in that cohort, more than half of participants (about 52 percent) had *already tried and failed* to come off their medication at least once. These were not easy cases. They were people exactly like you, and going slower in smaller steps is what changed the outcome. That is the heart of the message here. The earlier attempts were not a verdict on your strength or your need for the drug. They were a verdict on the taper speed.

Here is the honest catch, and the communities that support tapering are very open about it. Standard tablets and capsules are not designed to give you 1 mg, 0.5 mg, or 0.2 mg. So the final, most important stretch of a hyperbolic taper is also the most fiddly to physically achieve. There are a few established ways people bridge that gap, ideally worked out with a prescriber and pharmacist:

• Manufacturer or compounded oral liquids. A liquid lets you measure small, precise doses and dilute further with water. Some SSRIs, like citalopram, can be measured down to fractions of a milligram this way.
• Tablet splitting. Pill cutters and scales let you quarter or weigh tablet fragments, though unscored or oddly shaped tablets split less reliably.
• Bead counting. Some capsules, such as certain venlafaxine formulations, contain tiny beads that can be counted or weighed to step down gradually.
• Compounding pharmacies. These can prepare custom low-dose capsules or suspensions when off-the-shelf options run out.

None of this is exotic, but it is detailed, and getting a single step wrong can derail a week. This is the practical reason so many tapers stall right at the finish line, and it is where careful planning pays off most.

You do not have to figure this out alone, and some of the best help is free. The peer communities have carried this knowledge for years, often before mainstream medicine caught up. Surviving Antidepressants maintains detailed tapering guidance and member-tested methods for liquids and splitting. BenzoBuddies offers support specifically for benzodiazepine withdrawal. The Ashton Manual, written by Professor Heather Ashton, remains the foundational reference for slow benzodiazepine tapering. Inner Compass Initiative and The Withdrawal Project provide layperson-friendly education and peer connection. And the Maudsley Deprescribing Guidelines give clinicians the dose-by-dose science to back it all up. Treat these as allies; many people use them alongside their prescriber.

Where the work gets overwhelming is translating those principles into *your* numbers: your drug, your starting dose, your formulation, and a concrete dose for each day. That is the one thing Subside is built to do. It can turn the hyperbolic method into a personalized, day-by-day schedule, including the practical recipe for reaching those small end-of-taper doses, that you can print and review with your prescriber. It is meant to make the plan legible and shared, not to replace the clinician who knows you.

This article is education, not medical advice, and it cannot account for your individual history. Please do not change your medication based on it alone.

Taper with a prescriber who knows your situation. This matters most for benzodiazepines and for severe or long-standing dependence, where stopping abruptly can be dangerous and, in the case of benzodiazepines, can cause seizures. Never stop these medications cold. The point of hyperbolic tapering is the opposite of abruptness: slow, gradual, and adjustable, with the freedom to hold or pause whenever you need to. If you are in crisis or having thoughts of harming yourself, contact your local emergency number or a crisis line right away.

Going slowly is not weakness or overcaution. For most people, slow and hyperbolic is simply what works.